ClinicalTrials.gg
RecruitingNCT07526766Updated Nov 17, 2026

A Study Of Exercise In Patients With Spontaneous Coronary Artery Dissection And Fibromuscular Dysplasia

An interventional study of Aerobic and resistance exercises in Fibromuscular Dysplasia and Spontaneous Coronary Artery Dissection, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 21 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 2 months later.
Updated Nov 17, 2026Study contact changedStart date movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Not applicable
Ages
21 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States — 8 open to participants now, 9 under way, none of them phase 3. Coronary Artery Dissection, Spontaneous · United States.

Started
2026
with 2 others
No phase
2 of 13
2 open now
Registered
12th of 13
by date
Lead sponsor
8 of 13
Mayo Clinic

Among the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, this one is one of 3 that started in 2026, is one of 2 with no phase, and was the 12th registered.

Coronary Artery Dissection, Spontaneous

28 studies on the registry are indexed under Coronary Artery Dissection, Spontaneous; 18 are open to participants now.

Browse Coronary Artery Dissection, Spontaneous studies →

Open to participants now

8 of the 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 13 Coronary Artery Dissection, Spontaneous studies recruiting now, 11 (85%) set no upper age limit and 1 (8%) stops at 75 or younger; 1 takes children under 18; 5 take healthy volunteers.

This study: 21 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Coronary Artery Dissection, Spontaneous with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to assess the cardiopulmonary, hemodynamic, and symptom responses to acute bouts of varying intensity aerobic and resistance exercise in people with Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD).

03

Conditions studied

  • Fibromuscular Dysplasia
  • Spontaneous Coronary Artery Dissection
04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • History of Spontaneous Coronary Artery Dissection (SCAD) and/or Fibromuscular Dysplasia (FMD), ≥2 months post-event, and free from chest pain.
  • Able to provide written

Exclusion criteria

Exclusion criteria:

  • Individuals who are clinically obese ( ≥36) and/or who suffer from musculoskeletal or other conditions that would limit exercise participation.
  • Individuals who are deemed medically unstable
  • Participants who are unable to comply with study requirements.
  • Pregnancy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
28 participants (estimated)

Study arms

  • Experimental
    Aerobic and resistance exercise

    Patients with a history of Spontaneous Coronary Artery Dissection and/or Fibromuscular Dysplasia will undergo three exercise tests.

    Behavioral: Aerobic and resistance exercises

Interventions

  • BehavioralAerobic and resistance exercises

    Subjects will undergo three exercise tests, each separated by at least 48 hours: * Symptom-limited cardiopulmonary exercise test (CPET): Patients will cycle upright starting at 0W (3 min) before the workload is increased by 10-35W·min-1 in a ramp fashion (like cycling up a progressively steeper hill) until volitional exhaustion for the determination of V̇O2peak and Wpeak * Two-stage submaximal constant power exercise test: Following a 5-minute warm-up (10-20 W), participants will cycle in the moderate intensity domain for 25 minutes followed by 25 minutes in the heavy intensity domain. * Six different resistance exercises of varying intensities: Participants will perform three sets of six different resistance exercises: chest press; lateral raises; abdominal crunches; planks; leg press; weighted lunges

06

What researchers measure

Primary outcomes

  1. Change in blood pressure in response to aerobic exercise

    Systemic blood pressure will be measured at rest, at peak exercise, and for 5 minutes of recovery after exercise via finger photoplethysmography and reported as mmHg

    Time frame: Baseline, 5 minutes, 25 minutes, 50 minutes and 55 minutes

  2. Dartmouth COOP Functional Assessment Chart score

    The Dartmouth COOP Functional Assessment Charts are a set of patient-reported, pictorial tools used to measure physical, mental, and social functioning. The tool includes 9 questions that are rated on scores from 1-5, with higher scores indicating worse function.

    Time frame: Baseline

  3. Duke Activity Index Status (DASI) score

    The Duke Activity Status Index (DASI) is a self-administered questionnaire that measures a patient's functional capacity. It consists of 12 yes/no questions. Scores range from 0 to 58.2, with higher scores indicating better exercise capacity.

    Time frame: Baseline

  4. International Physical Activity Questionnaire Short Form (IPAQ-SF) score

    The International Physical Activity Questionnaire Short Form (IPAQ-SF) is a 7-item self-reported questionnaire where subjects report time spent being physically active in the last 7 days reported hours per day or minutes per day.

    Time frame: Baseline

  5. Change in perceived exertion

    Perceived exertion (breathlessness and leg fatigue) will be obtained using the Borg 0-10 scale.

    Time frame: Baseline, 25 minutes, and 50 minutes

  6. Change in blood lactate concentration [La-]b

    Blood lactate concentration \[La-\]b will be measured via analysis of a pinprick point-of-care lactate test (via the earlobe) at rest, during exercise, and at peak exercise.

    Time frame: Baseline, 25 minutes, and 50 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Aug 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 6, 2026
First posted
Apr 13, 2026
StartActual
Sep 1, 2026
Primary completionEst.
Aug 30, 2027
CompletionEst.
Nov 1, 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Sep 11, 2026→Sep 1, 2026 (actual)
Oct 22, 2026
Contact
Study contact changed: h•••@mayo.edu · •••0859→d•••@mayo.edu · •••2000. See the current contact
Nov 17, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Mayo Clinic in Florida · Jacksonville, United StatesContact h•••@mayo.edu · •••0859→d•••@mayo.edu · •••2000
Nov 17, 2026
Show all 2 updates
  1. Nov 17, 2026
    Contact Study contact changed: h•••@mayo.edu · •••0859→d•••@mayo.edu · •••2000. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Mayo Clinic in Florida · Jacksonville, United StatesContact h•••@mayo.edu · •••0859→d•••@mayo.edu · •••2000
    + 1 other change: verification date
  2. Oct 22, 2026
    Start date Sep 11, 2026→Sep 1, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07526766
Lead sponsor
Mayo Clinic
Responsible party
Elizabeth H. Dineen (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Apr 13, 2026
Start date
Sep 1, 2026
Primary completion
Aug 30, 2027 (estimated)
Completion
Nov 1, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Elizabeth H. Dineen, DO
Contact
dineen.elizabeth@mayo.edu
904-953-2000
Elizabeth H. Dineen, DO
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion